Abstract Objective To study the effect of the uncertain deflection of the Delta4 phantom (ScandiDos AB, Sweden) in setting up on the Gamma index passing rate during the VMAT plan verification. Methods Two patients with head and neck cancer, two with lung cancers and one with pelvic cancer receiving VMAT radiotherapy were randomly chosen. By means of Eclipse8.6 TPS the treatment plans elaborated for the five patients were picked up to make the verification plans and Delta4 was used to perform dose verification On VARIAN Clinac IX. The Delta4 phantom was precisely set up first, and then it was deflected in a given angle towards the horizontal direction in relation to the center of the linear accelerator isocenter to perform the dose verification for 11 times successively. To figure out the relationship between the deflection angle of the Delta4 phantom and the Gamma index passing rate. Results As the Delta4 phantom was deflected by 0.0°, 0.2°, 0.4°, 0.6°, 0.8°, 1.0°, 1.2°, 1.4°, 1.6°, 1.8° and 2.0° in sequence, the measured Gamma index passing rates presented a slight decline, but all greater than 90%(DD 3%, DTA 3 mm). Conclusions In the VMAT plan verification, the Gamma index passing rate of Delta4 has no dependence on the uncertain deflection of the Delta4 phantom provided that the uncertain deflection of the Delta4 phantom is no greater than 2°, but the passing rates of DD and DTA vary significantly with the uncertain deflection of the Delta4 phantom.
Corresponding Authors:
Wang Ying, Email:wangying_cq@hotmail.com
Cite this article:
Liu Xianfeng,Jin Fu,Zhong Mingsong et al. The study of angular dependence of gamma index for Delta4 phantom[J]. Chinese Journal of Radiation Oncology, 2014, 23(4): 357-360.
Liu Xianfeng,Jin Fu,Zhong Mingsong et al. The study of angular dependence of gamma index for Delta4 phantom[J]. Chinese Journal of Radiation Oncology, 2014, 23(4): 357-360.
[1] Cilla S, Caravatta L, Picardi V, et al. Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer[J]. Clin Oncol,2011,24:261-268. [2] Lu SH, Cheng JC, Kuo SH, et al. Volumetric modulated arc therapy for nasopharyngeal carcinoma:a dosimetric comparison with TomoTherapy and step-and-shoot IMRT[J]. Radiother Oncol,2012,104:324-330. [3] Palma D, Vollans E, James K, et al. Volumetric modulated arc therapy for delivery of prostate radiotherapy:comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy[J]. Int J Radiat Oncol,2008,72:996-1001. [4] Ling CC, Zhang PP, Archambault Y, et al. Commissioning and quality assurance of RapidArc radiotherapy delivery system[J]. Int J Radiat Oncol,2008,72:575-581. [5] Korreman S, Medin J, Kjer-Kristoffersen F. Dosimetric verification of RapidArc treatment delivery[J]. Acta Oncol,2009,48:185-191. [6] Bedford JL, Lee YK, Wai P, et al. Evaluation of the Delta4 phantom for IMRT and VMAT verification[J]. Phys Med Biol,2009,54:167-176. [7] Low DA, Harms WB, Mutic S, et al. A technique for the quantitative evaluation of dose distributions[J]. Med Phys,1998,25:856-661. [8] Depuydt T, Van Esch A, Huyskens DP. A quantitative evaluation of IMRT dose distributions:refinement and clinical assessment of the gamma evaluation[J]. Radiother Oncol,2002,62:309-319. [9] Bakai A, Alber M, Nusslin F. A revision of the gamma-evaluation concept for the comparison of dose distributions[J]. Phys Med Biol,2003,48:3543-3553. [10] 张伟,马照,邵鹏,等.Delta4的临床应用研究[J].中华放射肿瘤学杂志,2010,19:48-51.
2014, Vol. 23 
